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High levels of the p53 tumor suppressor protein can block progression through the cell cycle. A model system
for the study of the mechanism of action of wild-type p53 is a cell line (T64-7B) derived from rat embryo
fibroblasts transformed by activated ras and a temperature-sensitive murine p53 gene. At 37 to 39°C, the
murine p53 protein is in a mutant conformation and the cells actively divide, whereas at 32°C, the protein has
a wild-type conformation and the cells arrest in the G, phase of the cell cycle. Wild-type simian virus 40 large
T antigen and a variety of T-antigen mutants were assayed for the ability to bypass the cell cycle block effected
by the wild-type p53 protein to induce colony formation at 32°C. The results indicate that two functions within
the amino terminus of T antigen are essential to induce cell growth: (i) the ability to bind to the retinoblastoma
protein, Rb, and (ii) the presence of a domain in the first exon that appears to interact with the cellular protein,
p300. Thus, the cell cycle arrest triggered by wild-type p53 may be overcome by formation of a T-antigen
complex with Rb, p300, or both that could then function to either remove p53-mediated negative growth
regulatory signals or promote a positive cell growth signal. Surprisingly, T antigen-p53 complexes are not
required to overcome the temperature-sensitive p53 block to the cell cycle in these cells. These data suggest that
simian virus 40 T antigen associated with Rb, p300, or both proteins can communicate in a cell with the
functions of the wild-type p53 protein.
The p53 protein is encoded by a tumor suppressor gene.
About 60% of human cancers contain mutations at the p53
locus (23, 30). Most commonly, one p53 allele contains a
missense mutation producing a faulty protein, while the second
allele is lost by a reduction to homozygosity, leaving no
wild-type protein in the cancer cells (1). This is the expected
pattern for a tumor suppressor gene, in which a loss of function
results in abnormal growth control. The validity of this interpretation was demonstrated by the creation of mice without
normal p53 genes; all of these animals developed cancers in
the first 3 to 6 months of life (8). Reintroduction of the
wild-type p53 gene into cells which are being transformed by
oncogenes (15) or are already transformed (36) blocks the
transformation process or reduces the tumorigenic potential of
the cells (4). When the wild-type p53 protein is expressed at
high levels in these cells, it stops cell proliferation (35, 38).
Cells transformed with a temperature-sensitive p53 mutant
divide at 37 to 39°C when the p53 protein is in the mutant form
but fail to divide at 32°C when the p53 protein is primarily in
a wild-type conformation and acts as a tumor suppressor gene
product (35, 38). The wild-type p53 protein blocks progression
through the cell cycle in G, (35, 38). Thus, under certain
circumstances, the wild-type protein can regulate the passage
of cells through the cell cycle. Several studies have demonstrated that the wild-type p53 protein, but not the mutant p53
protein, can act as a transcription factor or a negative regulator
(14, 26, 50, 62), and so it is tempting to suggest that the
p53-mediated transcription of a set of genes can block passage
through the cell cycle in the GI phase of this cycle.
Simian virus 40 (SV40) initiates tumors in animals (1 1, 17)
*

and transforms cells in culture (56) because of the transforming properties of the virus-encoded oncogene product, large T
antigen (3). An extensive genetic analysis of large T antigen (5,
27, 31, 45, 51-53, 55, 60, 65, 66) has localized three distinct
domains of this protein that are required for the transformation of a variety of cell types in culture. SV40 large T antigen
is composed of 708 amino acid residues, and amino acid
sequences within residues 1 to 82, 105 to 114, and 351 to 626
are critical for the transformation process. Mutations within
the first exon of T antigen (residues I to 82) are complemented
for transformation by the adenovirus oncogene EIA (60). EIA
proteins bind to a cellular protein termed p300 (10), and EIA
mutant proteins that have lost the EIA-p300 interaction fail to
complement SV40 T-antigen mutants with mutations in residues 1 to 82 (60). Although not yet demonstrated directly,
these results suggest that some of these SV40 large T-antigen
residues may bind to the cellular p300 protein and alter p300
functions, resulting in cellular transformation. Residues 105 to
114 of SV40 large T antigen are critical for binding to the
retinoblastoma susceptibility protein (Rb) (6), which is a tumor
suppressor protein regulating the transcription factor E2F,
which in turn is thought to regulate entry into the S phase of
the cell cycle (10, 58). SV40 T antigen also binds to the
wild-type p53 protein (28, 32). The ability of T antigen to form
a complex with p53 correlates with its ability to immortalize
primary murine cells in culture (27, 67) and is also required for
extending the life span of human cells (31) and for the
transformation of certain immortal cell lines (53, 65). While in
vitro binding studies showed that T-antigen residues 273 to 517
were required for T-antigen binding to the wild-type p53
protein (41, 48), immortalization assays have demonstrated
that both the immortalization and T antigen-p53 binding
functions are affected by mutations within residues 351 to 626
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TABLE 1. Characteristics of wild-type and mutant SV40 virus large T-antigen proteins

Wild type
- p300 complementing
function
-Rb binding
- p53 binding

-NLS
-DNA binding
Zn finger

Transformation"'motliain
Immortalization.

Amino acid changeT

Construct

Phenotype"

B3
2803

A35 + in (5)

dll135
2831
pVU-l
KI
dll 137
2809
2811
pSVcT

A17-27
A5-35 + in (5)
A106-113 + in (1)
E107K
A122-708 + in (11)
A409 + in (5)
in 424 (4)
K128N
A168-346 + in (4)

2837/p6-l

C3HlOTI/2

REF52

Rat-I

primary MEF

+

+

+

+

-

-

ND

+

+

-

-

+

+

-

ND

+
+

+
+

ND
ND

+
+

" A region in the extreme amino terminus of T antigen, required to transform the immortal murine line, functionally complements a non-p3()-binding EIA deletion
mutant in a transformation assay (60). NLS, nuclear localization signal.
' A, amino acid deletion; in, amino acid insertion (number of amino acids inserted). Letters denote amino acid residues; numbers not in brackets denote atmino acid
positions.
'*The activities of mutant and wild-type T antigens in transformation and immortalization assays are as reported from the following sources: C3H Il()TI/2 (44. 53. 68).
REF52 (45. 53, 68), Rat-I (25), mouse embryo fibroblasts (MEF) (5, 66). ND, not determined.

(27, 66) in two noncontiguous regions, residues 351 to 450 and
533 to 626 (27). When T antigen binds to p53, it inactivates its
ability to bind to DNA and act as a transcription factor at a
p53-responsive element (14, 39, 49), just as mutations in the
p53 gene block this same function (14, 26, 62). Thus, T antigen
mediates its ability to transform cells by binding to or interacting with three cellular proteins, Rb, p53, and possibly p300,
which are thought to play critical roles in cell cycle events.
The study reported here used a cell line transformed by an
activated ras oncogene and a temperature-sensitive p53 mutant. At 32°C, these cells arrest in the G phase of the cell cycle,
and the ability of the SV40 large T antigen to overcome this
temperature-dependent block in cell division was examined.
The role of the T-antigen N terminus (p300) and the Rb and
p53 binding sites in T antigen was assessed by using mutants in
each of these regions of the T-antigen gene and determining
their ability to overcome the p53-mediated block to cell
division. Surprisingly, the T-antigen p53 binding site was not
required to overcome the p53-initiated G, block in the cell
cycle. Instead, both the p300 site and Rb-T antigen complexes
were needed to inactivate the p53 temperature-sensitive block
to cell division. T-antigen proteins with mutations in either the
N-terminal region (p300) or the Rb binding site failed to
inactivate the p53 block in the cell cycle, but these individual
mutations could complement each other to produce cell lines
that grew at 32°C. These results demonstrate that the N
terminus of T antigen (p300) and the Rb binding site functionally interact with the p53 protein. Two distinct models that
predict different sets of interactions are proposed.

MATERIALS AND METHODS
Plasmids. The following vectors that code for mutant SV40
T antigen contain the entire EcoRI-digested SV40 genome
cloned into the EcoRI site of pUC18: pSVcT (29), 2803, 2809,
and 2811 (67), 2831 (68), and 2837/p6-1 (66). T-antigen mutant
vectors Ki and pVU-1 contain early-region SV40 DNA cloned
into pBR328 (25). Vector B3 (43) (which codes for wild-type
SV40 T antigen) and the mutant vectors dll 135 and d11137
contain the entire BamHI-digested SV40 genome cloned into
the BamHI site of pBR322 (45). Vector pSVgem codes for
wild-type T antigen and contains early-region SV40 DNA

cloned into pGEM (Promega). The pBluescript vector BSKS (Stratagene) was used as a negative control. The properties of
these mutant vectors are summarized in Table I and Fig. 3.
Cell culture and DNA transfections. T64-7B cells (22) were
maintained in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 10% fetal bovine serum at 37°C in a
humidified, 5% CO2 atmosphere. For the colony formation
assay, 2 x 105 T64-7B cells were seeded at 37°C into 10-cmdiameter dishes. Cells were transfected 1 day later by the
calcium phosphate procedure (18) with equimolar amounts of
plasmid DNA and 10 or 15 [Lg of salmon sperm DNA as
carrier. Eighteen hours later, the transfected cells were rinsed
twice with phosphate-buffered saline (PBS), replenished with
fresh DMEM, and shifted to 32°C. Culture medium was
changed every 5 to 6 days, and colonies were cloned and/or
scored by staining with crystal violet 21 to 25 days later.
Immunoprecipitations. Cells were metabolically labeled for
4 h with 100 ,uCi of [35S]methionine EXPRESS (DupontNEN) in 2 ml of methionine-free DMEM plus 2% PBSdialyzed fetal bovine serum. Labeled cells were rinsed with
cold PBS, scraped from the plates, pelleted, and stored at 80°C
prior to lysis. Cellular protein lysates were prepared in lysis
buffer (50 mM Tris-Cl [pH 8.0], 5 mM EDTA, 150 mM NaCl,
0.5% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 0.28
trypsin-inhibiting units of aprotinin [Sigma] per ml) and precleared with protein A-Sepharose (Sigma). Immunoprecipitations were carried out with 106 to 107 trichloroacetic acidprecipitable cpm of lysates with appropriate antibodies and
protein A-Sepharose, rotating at 4°C for at least 2 h. Immune
complexes were washed twice in SNNTE buffer (50 mM Tris
[pH 7.4], 5 mM EDTA, 5% sucrose, 1% Nonidet P-40, 0.5 M
NaCl) and once in radioimmunoprecipitation assay buffer (50
mM Tris [pH 7.4], 150 mM NaCl, 1% Triton X-100, 0.5%
sodium dodecyl sulfate, 1% [wt/vol] sodium deoxycholate),
boiled, and separated on polyacrylamide gels. Gels were fixed
(30% methanol, 10% acetic acid), washed in H,O, and prepared for fluorography in 1 M sodium salicylate-5% glycerol.
The gels were dried under vacuum and exposed to Kodak
XAR-5 film at - 80°C. The following monoclonal antibodies
were used: M73 (21), 2A6 (47), 246 (61), 240 (16), 416, 419,
and 421 (20), 412 (19), and 901 (27). Ascites fluid for 901 was
kindly provided by S. Tevethia (Pennsylvania State University).
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FIG. 1. Growth curves for T64-7B cells at 39°C (open squares) or
32°C (filled squares). A total of 105 cells in 10-cm-diameter plates were
shifted to 39 or 32°C and counted over a 150-h period.

RESULTS
The p53 temperature-sensitive cell line. A temperaturesensitive p53 protein is encoded by a murine mutant p53 allele
in which valine replaces alanine at codon 135 (38). This mutant
p53 allele (p53Va-135), plus the activated ras oncogene, will
transform primary rat embryo fibroblasts at 37 to 39°C but not
at 32-C (22, 35, 38). Cells transformed by these oncogenes
grow at 37°C, but at 32°C, the cells are blocked in the G, phase
of the cell cycle. The p53Val-135 protein is in a mutant conformation at 37 to 39°C and a wild-type conformation at 32°C
(35). In some of these cell lines, such Al-5 (22, 35), the p53
levels are very high, and transfecting wild-type SV40 T antigen
into these cells does not relieve the block to cell division at
32°C, presumably because wild-type p53 is in excess to SV40 T
antigen in these cells (46). However, other temperaturesensitive p53-plus-ras-transformed rat embryo fibroblast cell
lines, such as T64-7B (22), have been generated which express
lower levels of wild-type p53 and still are blocked in their
progression through the cell cycle at 32°C (Fig. 1) predominantly in the G, phase of the cycle (a fluorescence-activated
cell sorting analysis of the DNA content of these cells shows
that 82% of the cells are in G1 and 15.7% of the cells are in G2
or M, while the remainder are in S phase; by contrast, at 370C,
20 to 25% of the growing cells are in S phase). This cell line will
grow at 32°C when the SV40 large T antigen gene is introduced
and expressed in these cells.
SV40 T antigen overcomes the temperature-sensitive p53mediated block in cell division. When T64-7B cells are plated
at 32°C in a culture dish, they fail to form colonies. By contrast,
when T64-7B cells are transfected with DNA containing the
entire SV40 genome (B3 DNA) or the SV40 large T-antigen
gene alone (pSVgem DNA) (transfected at 37°C for 18 h and
then shifted to 32°C to test for the formation of colonies on the
surface of a culture dish), then colonies of these cells are
readily detected (Fig. 2). When the vector BSKS alone is used
for these DNA transfection experiments, no colonies are
formed (Fig. 2). The colonies that arise in this assay are readily
cloned and expanded and grow continuously at 32°C. The cells
from these colonies all express SV40 T antigen, which is found
in cell extracts to be bound to the p53 protein (28, 32).
SV40 T-antigen mutant analysis of the rescue of p53 temperature-sensitive cell lines. To determine which functional
domains of SV40 large T antigen are required for this Tantigen-mediated rescue of the p53 temperature-sensitive
block in cell division, a variety of mutant T-antigen plasmids
(described in Table 1) were used. These mutants fall into five

|

FIG. 2. Morphology of T64-7B colonies that form at 32°C. Cells
were transfected as described in Materials and Methods with 5 ,ug of
wild-type (B3) or mutant (dll 137 or dll135) T-antigen vectors or with
the molar equivalent of a control vector (BSKS) and stained with
crystal violet 3 weeks following the temperature shift to 32°C.

classes: mutants that fail to provide the T-antigen p300complementing function (2803, dlll35, and 2831) (class 1),
mutants that fail to bind the Rb protein (pVU-1 and K1) (class
2), mutants that fail to bind the p53 protein (dll 137, 2809, and
2811) (class 3), a mutant lacking the nuclear localization signal
(pSVcT) (class 4), and a mutant that is defective in the
T-antigen zinc finger and does not bind to DNA (2837/p6-1)
(class 5). The N-terminal binding site (p300), Rb, and p53
mutants are defective in various assays for transformation of
cells in culture, while the other two classes of mutants (classes
4 and 5) are not defective in these assays (Table 1).
Each of these mutant T-antigen genes and the wild-type
gene (B3) were tested by transfecting these DNAs into T64-7B
cells and shifting them to 32°C. When 2 x 105 cells were
analyzed in this fashion, wild-type T antigen yielded about 30
colonies (26 to 38 in three separate experiments) at 32°C, 14
days after the temperature shift (Fig. 2 and 3). Mutants that
were defective in the p300-complementing function failed to
form colonies (Fig. 3), giving only 0 to 5% of the wild-type
values, depending on the mutant allele tested. Mutants defective in Rb binding similarly failed to overcome the p53
temperature-sensitive block in cell division, yielding 2 to 3% of
the wild-type values (Fig. 3). By contrast, mutants defective in
p53 protein binding were 39 to 63% as efficient as wild-type T
antigen in rescuing the cells from the p53 block. Similarly, the
nuclear localization mutant and zinc finger mutant were quite
efficient (76 to 87%) in overcoming the p53 block to cell
division. Examples of the colonies produced at 32°C with
dll137 (a T-antigen mutant that does not bind p53) or the
failure to form colonies with d11135 (a mutant for p300complementing function) are shown in Fig. 2, and all of the
results are summarized in Fig. 3.

SV40 T-ANTIGEN FUNCTIONS REQUIRED FOR GROWTH INDUCTION

VOL. 68, 1994

Phenotype

p300
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r

NLS
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bindfing

Wild Type

B3

Activity
Relative to
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Finger

_

u

(1)

Rb/pl1 07

Avg

WT TAg

28, 38, 26

30.7

1.00

0, 1, 0

0.3

0.01

0, 0, 0

0

0

0, 5, 0

1.7

0.05

1, 1,0

0.7

0.02

0, 0, 3

1.0

0.03

7,17, 23

_

(7CJ8)

Helicase

L2803
- p300

# Colonies
ATPase

VIA
(

1337

linker (35)

Complement
Function

dl 135
17-27

_ 2831

LA
5-35

-

pVU-1

Rb Binding
_

L11
106-113

Kl
El 07K

dFl1137
- p53 Binding

2809

L

122-708

15.7

0.51

5, 21, 10

12.0

0.39

6, 33, 19

19.3

0.63

17, 26, 27

23.3

0.76

8, 36, 36

26.7

0.87

linker (409)
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FIG. 3. Compiled results of three complete assays testing the ability of wild-type and mutant T-antigen proteins to induce T64-7B cells to form
colonies at 32°C. The mutational lesions affecting particular amino acid residues in each mutant T-antigen protein are indicated schematically
below a diagram of the wild-type SV40 T-antigen protein, where various functional domains have been delineated (pol a*, polymerase o*; NLS,
nuclear localization signal). The three values reported for each T antigen tested reflect the number of colonies formed on a single plate of cells
transfected in each of three separate experiments. Avg, average number of colonies for the three experiments; WT TAg, wild-type T antigen.
Quantities of plasmid used for the transfections were in molar equivalents to 5 p.g of wild-type vector B3. No colonies formed at 32°C following
transfection with control vector BSKS.

These results indicate that the large T-antigen functions
clustered in the first 121 amino acids of T-antigen (dll137 has
only those residues) are sufficient to overcome the p53 temperature-sensitive block to cell division. Cell lines expanded at
32°C with either the wild-type T antigen (Fig. 4A) or the dll 137
T-antigen mutant (Fig. 4B) expressed T-antigen proteins.
These cells were labeled with [ 5S]methionine for 4 h, and
soluble protein extracts were prepared. These extracts were
subjected to immunoprecipitation analyses using a variety of
monoclonal antibodies. M73 (recognizes adenovirus ElA proteins) and 2A6 (detects the adenovirus ElB 55-kDa protein)
were used as negative controls in these experiments; 419 and
412 detect an N-terminal set of residues of SV40 T antigen; 901
detects residues 684 to 698 of SV40 T antigen, while 416
interacts within residues 82 to 271 of T antigen; 421 detects all
forms of the p53 protein; 240 detects only mutant forms of the
p53 protein; and 246 detects only the wild-type form of the p53
protein. The wild-type T antigen was observed in a T antigenp53 complex in extracts from these cells (Fig. 4A), while the
dll 137 T antigen which was present in the T64-7B cells
transfected with this plasmid was not complexed to wild-type
p53 which was also present in these cells (Fig. 4B). In these
experiments, it is common that PAb240 detects a small percentage of wild-type p53 protein that is presumably denatured
during preparation of the antigen (Fig. 4B). The levels of p53

in the wild-type T antigen-p53 complex are much higher than
in the parental T64-7B cells (data not shown), probably
because of the enhanced stability of p53 in a T antigen-p53
complex (33). p53 levels (100% is in the wild-type conformation at 32°C) were much lower in the dll137-rescued T64-7B
cells, in which T antigen is not complexed with p53. There was
no suggestion in these experiments that dll137 mutant T
antigen stabilized p53 levels in these cells.
Colonies grown at 32°C expressing a variety of different
T-antigen mutants (Table 1 and Fig. 3) were cloned, expanded,
and grown into cell lines. These lines were assayed for the
presence of the SV40 T antigen in the same manner as
described above. Nine cell lines derived from either of two
wild-type constructs and 17 cell lines rescued by the different
SV40 T-antigen mutants capable of inducing colonies at 32°C
all expressed the transfected SV40 T antigen and retained this
expression after extensive growth at 32°C (Table 2).
The amino-terminal T-antigen functions complement to
overcome the p53-induced growth arrest. These experiments
demonstrate that the T-antigen p300-complementing and Rbbinding functions are both required to overcome the p53
temperature-sensitive block to cell division. If both are required as independent genetic units or functions, then mutations affecting each function may complement each other in a
cell. Alternatively, the T antigen-p300 and T antigen-Rb
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TABLE 2. Summary of immunoprecipitation analyses of cell lines
cloned from colonies that were selected at 32°C

~col~

1$'V¾.t~

No. of cell lines expressing
T antigen/no. examined

Input T-antigen
construct

200

Wild type
7/7
2/2

pSVgem .................................
97.4
_

68

-

-_
43

B

*TAg

B3 .................................
Mutant

_

_l

p53

200
97.4
68
-

p53

-

dIll 37 T Ag

43

29

18.4

5/5

2809 .................................
2811 .
.................................

4/4
3/3
2/2
3/3

pSVcT ..................................
2837/p6-1 .................................

-

I? 0oe ts Io 06

dll137 .................................

mutant (d11135 or 2831), no complementation was ever observed (eliminating recombination as an explanation for the
previous results). It has been suggested, however (34), that this
deletion mutation also alters the binding of p300 protein to T
antigen. All of the cell lines grown at 32°C containing Kl plus
2831 were found to express T-antigen proteins that form a
complex with the p53 protein at 32°C (data not shown). This
experiment also demonstrates that mutants Kl and 2831
produce stable T-antigen protein levels comparable to those of
the wild-type protein. Therefore, the inability of these mutants
to overcome the p53 block to cell division, when expressed
individually in T64-7B cells, is very likely due to the loss of
growth-promoting functions in these proteins.

DISCUSSION

14.3

FIG. 4. Expression of T antigen and p53 in T64-7B-derived cell
lines that grow at 32°C. (A) A cell line that was rescued for growth at
32°C by wild-type T antigen (T Ag) was metabolically labeled with
[35S]methionine, and equal amounts of trichloroacetic acid-precipitable protein (8.8 x 10' cpm) were subjected to immunoprecipitation
and gel electrophoresis as described in Materials and Methods. This
autoradiograph is an 18-h exposure. Monoclonal antibody M73, which
is specific for adenovirus EIA protein, was used as a negative control.
Monoclonal antibodies 419, 412, 416, and 901 recognize different
epitopes on the T-antigen protein, and antibody 421 recognizes p53.
(B) Immunoprecipitation analysis of a cell line rescued for growth at
32°C by the truncated T-antigen mutant dll137. A total of 1.4 x 106
precipitable counts was used for each immunoprecipitation. The
adenovirus 55-kDa E1B protein-specific antibody 2A6 served as a
negative control and detects cross-reacting proteins in the cell; antibody 240 recognizes only mutant p53, and antibody 246 recognizes
only wild-type murine p53. Sizes are given in kilodaltons.

functions might need to act on the same molecule in cis to each
other, in which case no complementation would be observed.
To test this hypothesis, 2831 (p300 defective) and KI (Rb
defective) were transfected separately or were cotransfected
into T64-7B cells, which were then shifted to 32°C. The SV40
wild-type T antigen (B3) yielded 21 colonies at 32°C, while
2831 yielded no colonies and KI produced one colony at 32°C
(Table 3). The 2831-plus-Kl complementation test produced
about 25% of the wild-type level of colonies, corresponding to
a fivefold increase above the background of the KI mutant
clone alone, indicating complementation between these defective gene functions.
When the pVU-1 (Rb-defective) mutant was used in
complementation tests with an N-terminal T-antigen-defective

The SV40 large T-antigen gene encodes three distinct gene
functions that are required to transform a variety of cells in
culture: (i) a p300 protein-complementing activity that maps to
within residues I to 82, (ii) an Rb-inactivating activity that
maps to residues 105 to 114, and (iii) a p53-binding and
inactivating region that maps to sequences within residues 351
to 626. It should be pointed out that the Rb binding site of T
antigen also binds to two other proteins, p107 and p130. Thus,
the properties ascribed to Rb-binding mutants of T antigen in
this report could also be mediated by p107 and/or p130.
Similarly, other functions of the T-antigen domain from residues 1 to 82 (not only the putative p300 binding site) could
mediate the release from a p53 GI arrest. Each of these three
regions of T antigen and their functions can contribute to the
transformation of some cell types (Table 1). In this study,
different T-antigen mutants deficient in each of these functions
were tested to determine which domains are required to
overcome a p53-mediated block in cell division. This is an assay
which is clearly distinct from transformation, but it is expected
TABLE 3. Complementation analysis
Growth'
Protein

Negative control"
B3
2831
KI
KI + 2831
"

per

Activity relative

to

wild-type SV4t)

Expt

Expt

Expt

1

2

3

Avg

large T antigen

0
27.5
0
2
6.5

0
16.5
0
0
7

0
20.5
0
0
2.5

0
21.5
0
0.5
5.33

0
1.0
0
0.02
0.25

Average number of colonies per plate that
experiment).
BSKS plus carrier DNA was assayed.

grew at

32°C (one to three plates
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FIG. 5. Alternative models that interpret the results and predict relationships between the functions of p300, Rb, and p53.

to be related in some fashion. Surprisingly, the results demonstrate that p53 binding by T antigen was not required to
overcome the p53 block to cell division. In fact, a mutant
(dll 137) containing only T-antigen amino acid residues 1 to

121 was 50% as efficient as the wild-type T antigen in overcoming this block. Because all of the experiments in this study
were carried out in a single cell line, T64-7B, one might be
concerned that an additional temperature-sensitive event (in
addition to the p53 protein) could affect these results. This is
unlikely, however, because Michael-Michalovitz et al. (37)
showed, with completely different cells, that an SV40 T-antigen
mutant containing residues 1 to 272 was sufficient to overcome
the ability of wild-type p53 to suppress transformation and to
induce growth arrest. Thus, these results appear to be of
general applicability to T antigen-p53 interactions.
While the T antigen-p53 binding site is not required for
inactivation of p53-mediated growth arrest, the T-antigen N
terminus (p300) and T antigen-Rb interactions are required to
overcome the wild-type p53 cell cycle block. The complementation of T-antigen N-terminal mutants (p300) and T antigenRb-defective mutants indicates that each can act in trans and
provides an independent function, without requirement for a
single protein with both T antigen-p300 and T antigen-Rb
interactive activities. These complementation studies also
demonstrate that these mutants fail to relieve p53-mediated
growth suppression despite the fact that the levels of mutant T
antigen in a cell should be sufficient to do so.
These experimental results demonstrate that the T-antigen
N-terminus (p300) and T antigen-Rb functions can communicate with the wild-type p53 and reverse its GI block in the cell
cycle. Two distinct models can explain these results (Fig. 5).
First, complexes between T antigen and cellular proteins
(p300, Rb, or both) could induce a set of enzyme activities in
these cells, such as protein kinases or protein-modifying enzyme activities, which may act on p53 and alter its activity in
the cell cycle. For example, it has been suggested that phosphorylation modification at the casein kinase II site (human
p53 residue 392) may alter p53 DNA-binding activity (24) and
may be important to its growth suppressor activity (40). p53 has

serine residue that appears to be phosphorylated by a
cyclin-dependent kinase activity (2), and p107, which binds to
the T antigen-Rb binding site (9, 12), is associated with cyclin
A-p34 protein kinase activities (10). It is not clear what effect
phosphorylation of the cyclin-dependent kinase site has on p53
activity, but the results presented here suggest that T-antigen
functions that may affect phosphorylation pathways are required to overcome p53-mediated growth arrest. A cellular
oncogene product, Mdm-2 (13), has been shown to bind to p53
and inactivate its function as a transcription factor (42). A T
antigen-p300-Rb complex might affect the level or activity of
Mdm-2 in these cells, which could then play a role in the
inactivation of wild-type p53 by T antigen. In either case, this
model (Fig. 5, model 1) suggests that the putative T antigenp300 complex and the T antigen-Rb complex induce a set of
functions which bypass or inactivate the p53 block to G, cell
cycle progression. The experimental data do not eliminate the
possibility that repression is also involved in these activities.
In contrast to that interpretation (Fig. 5, model 2), it remains
possible that the T64-7B cells rely on the expression of mutant
p53 protein at 37 to 39°C to continue to divide and progress
through the cell cycle. Mutant p53 proteins have recently been
shown to have a gain of a new function in transformed cells (7).
A mutant p53 protein expressed in a cell with no endogenous
p53 protein does indeed provide the ability to divide (form
tumors in animals) under circumstances in which the parental
cells fail to grow. In addition, it has been clearly shown that in
mutant p53-plus-ras-transformed rat embryo fibroblasts (such
as T64-7B cells), the expression of the mutant p53 protein is
continuously required for cells to replicate at an optimal
growth rate (63). The presence of mutant p53 protein enhanced the growth rate of these cells by about 3.7-fold. In the
present study, the mutant p53 gain of function would be lost
when cells are shifted to 32°C, and the cells would then fail to
divide because the p300 and Rb functions halt progression
through the cell cycle, resulting in a GI block. The presence of
SV40 T antigen with p300-complementing and Rb-binding
properties would alter p300 and Rb functions and therefore
permit cell division at 32°C. If this interpretation, which is
a

1340

QUARTIN ET AL.

consistent with all of the results presented here, is correct, then
the mutant p53 gain of function at 37 to 39°C would act on
p300 and Rb and, like T antigen, inactivate their functions.
Thus, model 1 (Fig. 5) suggests that the putative T antigenp300 complex and the T antigen-Rb complex communicate
with p53 via the induction or repression of activities that can
inactivate p53 function in the cell cycle. Model 2 suggests that
mutant p53 can act on p300 and Rb to alter their activities and
promote cell division much as T antigen-p300-Rb complexes
function to bypass or alter p300 and Rb functions. Both models
link p53 to p300 and Rb functionally. The two alternative
models either place T antigen-p300-Rb epistatic to wild-type
p53 or place mutant p53 epistatic to p300 and Rb in the G,
phase of the cell cycle. The virtue of these models is that they
make a set of predictions which can be tested. For example,
model 2 suggests that a mutant p53 protein that is not
temperature sensitive should overcome the p53 temperaturesensitive block at 32°C when DNA clones for this protein are
transfected into such cells. For the p53 mutant KH215 (54),
this indeed appears to be the case, although at a reduced
efficiency compared with the SV40 T antigen (46). Moreover,
the adenovirus ElA protein is known to bind to both p300 and
Rb proteins (58, 64), and the adenovirus p300 binding site
complements the SV40 T-antigen p300-defective mutants for
transformation (60). This finding suggests that the adenovirus
ElA proteins (10) might overcome the temperature-sensitive
p53 block in the T64-7B cells. Preliminary experiments demonstrate that the EIA oncogene can rescue these cells for
growth and colony formation at 32°C (46). Vousden and
coworkers (57) have recently shown that both ElA and the
human papillomavirus oncoprotein E7 can overcome wild-type
p53-mediated growth arrest. Thus, it is clear that the models
presented in Fig. S make testable predictions that should lead
to new insights into the relationships between p53, Rb, and
p300 and their roles in the regulation of cell division.
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